This conference is unique in that it stresses active audience participation and focuses on translating the best evidence and the latest developments regarding lung disease into clinical practice. The attendees list includes approximately 70 percent pulmonologists and 30 percent thoracic surgeons presenting an opportunity for participants to gain knowledge from each other's experiences in the Southeast.

The goal is to provide high level interaction between presenters and the audience that is facilitated by moderated case-based presentations in addition to traditional lectures. The program provides discussions and debates on medical, pharmacologic and surgical interventions, morbidity, quality of life and survival issues.